• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inflammatory bowel disease in Korea: epidemiology and pathophysiology.韩国的炎症性肠病:流行病学和病理生理学。
Korean J Intern Med. 2022 Sep;37(5):885-894. doi: 10.3904/kjim.2022.138. Epub 2022 Jul 29.
2
Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study.韩国大邱庆北地区儿科炎症性肠病的特征和发病趋势:一项多中心研究。
J Korean Med Sci. 2018 Apr 12;33(18):e132. doi: 10.3346/jkms.2018.33.e132. eCollection 2018 Apr 30.
3
Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018.2010-2018 年韩国炎症性肠病的流行病学和临床结局的最新趋势。
World J Gastroenterol. 2024 Mar 7;30(9):1154-1163. doi: 10.3748/wjg.v30.i9.1154.
4
Inflammatory bowel disease in Africa: what is the current state of knowledge?非洲的炎症性肠病:目前的知识状况如何?
Int Health. 2020 May 1;12(3):222-230. doi: 10.1093/inthealth/ihaa005.
5
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.欧洲炎症性肠病发病率的东西梯度:ECCO-EpiCom 起始队列。
Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.
6
Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.澳大利亚克罗恩病和结肠炎协会炎症性肠病审计:衡量澳大利亚的护理质量。
Intern Med J. 2019 Jul;49(7):859-866. doi: 10.1111/imj.14187.
7
Inflammatory bowel disease.炎症性肠病
Clin Cornerstone. 2002;4(4):49-60. doi: 10.1016/s1098-3597(02)90005-0.
8
A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.炎症性肠病的诊断、预防及治疗方法综述
J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075.
9
Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea.韩国济州岛三十年炎症性肠病趋势
Korean J Gastroenterol. 2023 Jun 25;81(6):243-252. doi: 10.4166/kjg.2023.006.
10
Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study.韩国炎症性肠病的新兴趋势:一项全国范围内基于人群的研究。
J Gastroenterol Hepatol. 2019 Jun;34(6):1018-1026. doi: 10.1111/jgh.14542. Epub 2018 Dec 10.

引用本文的文献

1
Colorectal Cancer Risk in Korean Patients with Inflammatory Bowel Disease: A Nationwide Big Data Study of Subtype and Socioeconomic Disparities.韩国炎症性肠病患者的结直肠癌风险:一项关于亚型和社会经济差异的全国性大数据研究
J Clin Med. 2025 Aug 5;14(15):5503. doi: 10.3390/jcm14155503.
2
Live strains from the mucosa of patients with ulcerative colitis: pathogenic potential and environmental adaptations.溃疡性结肠炎患者黏膜的活菌株:致病潜力与环境适应性
mBio. 2025 Jul 9;16(7):e0140025. doi: 10.1128/mbio.01400-25. Epub 2025 Jun 13.
3
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases.间充质干细胞衍生的外泌体作为一种用于炎症性疾病的合理免疫调节治疗工具。
Front Cell Dev Biol. 2025 Mar 10;13:1563427. doi: 10.3389/fcell.2025.1563427. eCollection 2025.
4
Exploring photobiomodulation in the management of bowel diseases: a concise critical review.探讨光生物调节在肠道疾病管理中的应用:简要的批判性综述。
Lasers Med Sci. 2024 Oct 27;39(1):265. doi: 10.1007/s10103-024-04217-6.
5
Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration.在静脉注射期间对生物化学应答不足的炎症性肠病患者进行皮下注射英夫利昔单抗转换治疗的效果。
Sci Rep. 2024 Oct 17;14(1):24347. doi: 10.1038/s41598-024-75693-7.
6
Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.韩国人群中肠道微生物标志物的生态失调特征及其在炎症性肠病中的诊断潜力。
Sci Rep. 2024 Oct 10;14(1):23701. doi: 10.1038/s41598-024-74002-6.
7
Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis.白藜芦醇用于炎症性肠病的临床前研究:一项系统评价和荟萃分析
Front Pharmacol. 2024 Jun 14;15:1411566. doi: 10.3389/fphar.2024.1411566. eCollection 2024.
8
Immunological relationship between and anti-tumor necrosis factor α agents in inflammatory bowel disease.炎症性肠病中[具体内容缺失]与抗肿瘤坏死因子α制剂之间的免疫关系。
Cent Eur J Immunol. 2024;49(1):70-76. doi: 10.5114/ceji.2024.136376. Epub 2024 Mar 25.
9
Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study.初治的中重度溃疡性结肠炎患者接受一线生物制剂和小分子药物治疗后组织学缓解的预测因素:一项单中心回顾性队列研究
Intest Res. 2024 Oct;22(4):453-463. doi: 10.5217/ir.2024.00044. Epub 2024 May 22.
10
Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018.2010-2018 年韩国炎症性肠病的流行病学和临床结局的最新趋势。
World J Gastroenterol. 2024 Mar 7;30(9):1154-1163. doi: 10.3748/wjg.v30.i9.1154.

本文引用的文献

1
Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review.炎症性肠病患者的营养治疗:叙述性综述。
Nutrients. 2022 Feb 10;14(4):751. doi: 10.3390/nu14040751.
2
Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020.2017年至2020年大邱-庆尚北道地区儿童炎症性肠病的发病率和患病率趋势
Front Pediatr. 2022 Jan 4;9:810173. doi: 10.3389/fped.2021.810173. eCollection 2021.
3
Natural history of inflammatory bowel disease: a comparison between the East and the West.炎症性肠病的自然史:东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.
4
Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.肛周克罗恩病的流行病学和自然史:基于人群队列的系统评价和荟萃分析。
Inflamm Bowel Dis. 2022 Oct 3;28(10):1477-1484. doi: 10.1093/ibd/izab287.
5
Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases.韩国炎症性肠病患者病毒感染性疾病的血清流行率及其相关因素。
Korean J Intern Med. 2022 Jan;37(1):73-84. doi: 10.3904/kjim.2020.386. Epub 2021 Sep 6.
6
The role of oral bacteria in inflammatory bowel disease.口腔细菌在炎症性肠病中的作用。
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):731-742. doi: 10.1038/s41575-021-00488-4. Epub 2021 Aug 16.
7
Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management.改善炎症性肠病(IBD)患者的护理:IBD 中心管理的观点和策略。
Korean J Intern Med. 2021 Sep;36(5):1040-1048. doi: 10.3904/kjim.2021.114. Epub 2021 Aug 5.
8
Clinical Features and Long-Term Outcomes of Paediatric-Onset Inflammatory Bowel Disease in a Population-Based Cohort in the Songpa-Kangdong District of Seoul, Korea.韩国首尔松坡-姜东区基于人群的队列中儿科发病炎症性肠病的临床特征和长期结局。
J Crohns Colitis. 2022 Feb 23;16(2):207-215. doi: 10.1093/ecco-jcc/jjab132.
9
Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.1986 年至 2015 年期间克罗恩病长期预后的变化:基于人群的宋帕-姜洞炎症性肠病队列研究。
Gut Liver. 2022 Mar 15;16(2):216-227. doi: 10.5009/gnl210044.
10
Pathophysiology of Inflammatory Bowel Diseases.炎症性肠病的病理生理学
N Engl J Med. 2021 Apr 8;384(14):1376-1377. doi: 10.1056/NEJMc2101562.

韩国的炎症性肠病:流行病学和病理生理学。

Inflammatory bowel disease in Korea: epidemiology and pathophysiology.

机构信息

Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

出版信息

Korean J Intern Med. 2022 Sep;37(5):885-894. doi: 10.3904/kjim.2022.138. Epub 2022 Jul 29.

DOI:10.3904/kjim.2022.138
PMID:35902371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9449206/
Abstract

Inflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly known as a disease of Western countries, the incidence and prevalence are increasing in Korea. Korean investigators have accumulated a great deal of knowledge about the regional characteristics and epidemiology of the disease, especially via well-organized, joint cohort studies. Against this background, this article describes the epidemiology of IBD in Korea compared to that in the West. In addition, an overview of the pathophysiology of the disease is provided, focusing on the latest results.

摘要

炎症性肠病(IBD)是一组疾病,包括克罗恩病和溃疡性结肠炎,它们具有相似但不同的表现。这些疾病的特点是肠道难治性和慢性炎症。IBD 通常伴有严重的症状。当患者出现疑似 IBD 时,医生在诊断和治疗方面会遇到各种挑战。此外,由于这些特点,相关医疗费用逐渐增加。虽然 IBD 以前被称为西方国家的疾病,但在韩国,其发病率和患病率正在上升。韩国研究人员通过精心组织的联合队列研究,积累了大量关于该疾病区域特征和流行病学的知识。在此背景下,本文描述了韩国与西方的 IBD 流行病学情况。此外,还概述了疾病的病理生理学,重点介绍了最新的研究结果。